Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_3
2
33%
Ph phase_4
3
50%

Phase Distribution

1

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 32 (33.3%)
Phase 43 (50.0%)

Trials by Status

completed233%
unknown233%
recruiting233%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_1

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

NCT06939582
recruitingphase_4

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

NCT04981145
completedphase_4

Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.

NCT02874287
unknownphase_3

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

NCT04403100
unknownphase_4

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

NCT04624269
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06939582Phase 1

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

Recruiting
NCT04981145Phase 4

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Recruiting
NCT02874287Phase 4

Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.

Completed
NCT04403100Phase 3

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

Unknown
NCT04624269Phase 4

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

Unknown
NCT04446104Phase 3

A Preventive Treatment for Migrant Workers at High-risk of COVID-19

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6